Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in June - Earnings Summary

Sonnet Biotherapeutics Holdings

14/08/2023 15:39

* Sonnet Biotherapeutics Holdings Inc  SONN.OQ  reported a
quarterly adjusted loss of 13 cents​​ per share for the quarter
ended in June. The mean expectation of two analysts for the
quarter was for a loss of 31 cents per share.
    * Revenue fell 40.4% to $37.00 thousand from a year ago. 
    * Sonnet Biotherapeutics Holdings Inc's reported EPS for the
quarter was a loss of 13 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Sonnet Biotherapeutics Holdings Inc shares had fallen
by 31.6%
this quarter and lost 70.9% so far this year.
    * Wall Street's median 12-month price target for Sonnet
Biotherapeutics Holdings Inc is $10.35 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 02:39 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.31          -0.13          Beat
 Mar. 31 2023      -0.49          -0.34          Beat
 Dec. 31 2022      -1.10          -0.80          Beat
 Sep. 30 2022      -1.51          -1.67          Missed